This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Fang Tan
Introduction
Fang Tan is a notable inventor based in Zhejiang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds. His work focuses on enhancing therapeutic options for various medical conditions.
Latest Patents
Fang Tan holds a patent for a benzimidazolone GLP-1 receptor agonist and its use. This invention is aimed at improving treatment strategies for conditions related to glucose metabolism. The patent showcases his expertise in medicinal chemistry and his commitment to advancing healthcare solutions. He has 1 patent to his name.
Career Highlights
Fang Tan is currently employed at Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. His role at the company allows him to engage in cutting-edge research and development. His contributions have been instrumental in the company's efforts to innovate and provide effective pharmaceutical products.
Collaborations
Fang Tan collaborates with talented professionals in his field, including Zhimin Zhang and Zhe Wang. These partnerships enhance the research environment and foster the exchange of ideas, leading to more robust innovations.
Conclusion
Fang Tan's work exemplifies the spirit of innovation in the pharmaceutical industry. His patent for a benzimidazolone GLP-1 receptor agonist highlights his dedication to improving healthcare. Through his career at Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd., he continues to make strides in medical research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile